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Policy  
From the WIC Services Policy and Procedure Manual —  
340.15 Ordering Print Materials 
The State WIC office provides clinic, nutrition and health education materials free of charge to local WIC 
agencies. Materials are stored at the Iowa Substance Abuse Information Center (ISAIC) and must be 
ordered using the Clearing House Ordering System. 
Information 
Iowa WIC Nutrition Services Coordinator Named 
Please join me in congratulating Jill Lange on her new position as WIC Nutrition Services Coordinator for 
the Iowa WIC Program. Jill has been worked as a consultant with the program since May 2007. She has 
represented the program on several division and department work groups, provided leadership to 
critical program activities including implementation of the new food packages, assisted with policy 
development and data system enhancements, and provided technical assistance to local WIC 
contractors.  
Jill will transition from her current responsibilities over the next several weeks. The transition will be 
complete when we fill her current Community Health Consultant position. More information about 
specific task assignments for the WIC consultants will be shared in the future. 
Congratulations, Jill! 
Resources 
AAP Clinical Report on Iron Deficiency and Iron-Deficiency Anemia 
Recently, the AAP released the article “Clinical Report Diagnosis and Prevention of Iron Deficiency and 
Iron-Deficiency Anemia in Infants and Young Children (0-3 Years of Age)” in the journal Pediatrics.  
Recommendations provided in the article mostly agree with current WIC nutrition risks including: 
 Universal screening for anemia, 
 Hgb cut-off level (11 mg/dL), 
 Use of iron fortified infant formula, and  
 No cow’s milk before 12 months of age. 
The article also includes a new recommendation that will require review by RISC for inclusion in the 
dietary risk for infants (#411). The AAP is now recommending that breastfed infants, beginning at 4 
months of age, be supplemented with 1 mg/kg/day of oral iron until appropriate iron-containing 
complementary foods are introduced into the diet. Partially breastfed infants (more than half of their 
daily feedings as human breast milk) who are not receiving iron-containing complementary foods should 
also receive 1 mg/kg/day of supplement iron. 
With the release of this new information, agencies should encourage breastfeeding moms to discuss 
infant iron supplementation with their health care provider. For more information, the full article from 
Pediatrics is included at the end of this document.   
Food Products 
The Pictsweet Company Announces a Voluntary Recall of Frozen Green Peas 
Due to Possible Health Risk 
Please see the below press release regarding a voluntary recall of frozen green peas. The major 
warehouses in Iowa have been contacted regarding this recall and the only warehouses supplying our 
stores with “possible” contamination are the WalMart Supercenters. According to WalMart the product 
has been removed from the shelf. 
HyVee, Fareway, Supervalu (Dahl’s supplier), AWG, (independent retailers) and Affiliated (independent 
retailers) supplied stores do not inventory this product.  
FOR IMMEDIATE RELEASE - October 15, 2010 - The Pictsweet Company of Bells, TN today announced a 
voluntary recall of certain codes of store brand products containing frozen Green Peas after the 
company learned that some of the packages may contain glass fragments, which may cause injury if 
ingested. 
Products subject to this recall were distributed only to Kroger stores in the Southeast United States and 
Walmart stores throughout the United States and include the following items: 
Kroger 12 ounce Green Peas (UPC 11110 89736) 
Production Codes of 1440BU, 1440BV, 1440BW, and 1600BD  
Kroger 12 ounce Peas and Carrots (UPC 11110 89741) 
Production Codes of 1960BD and 1960BE  
Great Value 12 ounce Steamable Sweet Peas (UPC 78742 08369)  
Best by Dates of July 20, 2012; July 21, 2012  
Great Value 12 ounce Steamable Mixed Vegetables (UPC 78742 08026) 
Best by Date of July 15, 2012 
No injuries have been reported to date. While no injuries have been reported, Pictsweet is advising the 
public that product from these packages indicated above should not be consumed. Consumers who 
have purchased the above product should return them to the place of purchase for a full refund. 
Consumers with questions may contact The Pictsweet Company at 1-800-367-7412, extension 417 toll-
free from 9:00 a.m. to 5:00 p.m. Central Daylight Time, Monday through Friday. 
Dates to Remember  
2010 
 October 25, 26  -  NETC 
 November 11  -  Limited Coverage 
 November 17, 2010 – Final PO/PV and Expenditures Report due to Bruce  
 November 17, 2010 – FFY2010 Year-End Progress Report due to Jill 
 November 30, 2010 – FFY2010 Water-Testing Summary due to Jill 
 December 1, 2010 – Year-End Expenditure Report due to Bruce 
 
2011 
 5th Monday clinics  
We do not anticipate any major changes to IWIN in 2011. Due to this, you can schedule clinics 
on the 5th Monday of the month if needed 
NETC 
 January 24 & 25 
 April 18 & 19 
 July 25 & 26 
 October 24 & 25 
Advisory Committee Meetings 
 March 4 
 July 15 
 October 7 
Core Workshops 
 March 28 & 29 - Maternal Nutrition and Breastfeeding Workshop  
 April 29 - Communication & Rapport Building Workshop  
 June 23 & 24 - Infant and Child Nutrition Workshop 
 
Available Formula 
 
Product Quantity 
Expiration 
Date 
Agency Contact 
Similac human milk fortifier 2 boxes 10/2010 Operation 
Threshold 
Nancy Anderson 
at 319-233-1851 
Peptamen 1.5 96 cans 12/2010 MICA Justine Hoover at 
641-752-7162 
Similac human milk fortifier 6 boxes  2/2011 Operation 
Threshold 
Nancy Anderson 
at 319-233-1851 
Enfaport Lipil  23 – 8 oz 
cans (ready-
to-feed) 
9/1/2011 Johnson County 
WIC 
Chuck Dufano at 
319-356-6042 
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Clinical Report—Diagnosis and Prevention of Iron
Deﬁciency and Iron-Deﬁciency Anemia in Infants and
Young Children (0–3 Years of Age)
abstract
This clinical report covers diagnosis and prevention of iron deﬁciency
and iron-deﬁciency anemia in infants (both breastfed and formula fed)
and toddlers from birth through 3 years of age. Results of recent basic
research support the concerns that iron-deﬁciency anemia and iron
deﬁciency without anemia during infancy and childhood can have long-
lasting detrimental effects on neurodevelopment. Therefore, pediatri-
cians and other health care providers should strive to eliminate iron
deﬁciency and iron-deﬁciency anemia. Appropriate iron intakes for
infants and toddlers as well as methods for screening for iron deﬁ-
ciency and iron-deﬁciency anemia are presented. Pediatrics 2010;126:
000
INTRODUCTION
Iron deﬁciency (ID) and iron-deﬁciency anemia (IDA) continue to be of
worldwide concern. Among children in the developingworld, iron is the
most common single-nutrient deﬁciency.1 In industrialized nations, de-
spite a demonstrable decline in prevalence,2 IDA remains a common
cause of anemia in young children. However, evenmore important than
anemia itself is the indication that themore common IDwithout anemia
may also adversely affect long-term neurodevelopment and behavior
and that some of these effects may be irreversible.3,4 Because of the
implications for pediatric health care providers and their patients, this
report reviews and summarizes this information.
This clinical report is a revision and extension of a previous policy
statement published in 1999,5 which addressed iron fortiﬁcation of
formulas. This report covers diagnosis and prevention of ID and IDA in
infants (both breastfed and formula fed) and toddlers aged 1 through
3 years.
DEFINITIONS
Anemia: A hemoglobin (Hb) concentration 2 SDs below the mean Hb
concentration for a normal population of the same gender and age
range, as deﬁned by the World Health Organization, the United Nations
Children’s Fund, and United Nations University.6 On the basis of the
1999–2002 US National Health and Nutrition Examination Survey, ane-
mia is deﬁned as a Hb concentration of less than 11.0 g/dL for both
male and female children aged 12 through 35 months.7,8 For certain
populations (ie, people living at high altitudes), adjustment of these
values may be necessary.
Robert D. Baker, MD, PhD, Frank R. Greer, MD, and THE
COMMITTEE ON NUTRITION
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iron deﬁciency, iron-deﬁciency anemia, iron intake, infants,
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ABBREVIATIONS
ID—iron deﬁciency
IDA—iron-deﬁciency anemia
Hb—hemoglobin
SF—serum ferritin
IOM—Institute of Medicine
WIC—Special Supplemental Program for Women, Infants, and
Children
CHr—reticulocyte hemoglobin
TfR1—transferrin receptor 1
CRP—C-reactive protein
AAP—American Academy of Pediatrics
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Iron sufﬁciency: A state in which there
is sufﬁcient iron to maintain normal
physiologic functions.
Iron deﬁciency: A state in which there
is insufﬁcient iron to maintain normal
physiologic functions. ID results from
inadequate iron absorption to accom-
modate an increase in requirements
attributable to growth or resulting
from a long-term negative iron bal-
ance. Either of these situations leads
to a decrease in iron stores as mea-
sured by serum ferritin (SF) concen-
trations or bone marrow iron content.
ID may or may not be accompanied by
IDA.
Iron-deﬁciency anemia: An anemia (as
deﬁned above) that results from ID.
Iron overload: The accumulation of ex-
cess iron in body tissues. Iron overload
usually occurs as a result of a genetic
predisposition to absorb and store
iron in excess amounts, the most com-
mon form of which is hereditary hemo-
chromatosis. Iron overload can also
occur as a complication of other hema-
tologic disorders that result in chronic
transfusion therapy, repeated injec-
tions of parenteral iron, or excessive
iron ingestion.
Recommended dietary allowance for
iron: The average daily dietary intake
that is sufﬁcient to meet the nutrient
requirements of nearly all individuals
(97%–98%) of a given age and gender.
Adequate intake for iron: This term is
used when there is not enough informa-
tion to establish a recommended dietary
allowance for a population (eg, term in-
fants, 0–6months of age). The adequate
intake isbasedon theestimatedaverage
nutrient intake by a group (or groups) of
healthy individuals.
IRON REQUIREMENTS FOR INFANTS
(UP TO 12 COMPLETED MONTHS
OF AGE)
Eighty percent of the iron present in a
newborn term infant is accreted dur-
ing the third trimester of pregnancy.
Infants born prematurely miss this
rapid accretion and are deﬁcient in to-
tal body iron. A number of maternal
conditions, such as anemia, maternal
hypertension with intrauterine growth
restriction, or diabetes during preg-
nancy, can also result in low fetal
iron stores in both term and preterm
infants.
Preterm Infants
The deﬁcit of total body iron in preterm
infants increases with decreasing ges-
tational age. It is worsened by the
rapid postnatal growth that many in-
fants experience and by frequent phle-
botomies without adequate blood re-
placement. On the other hand, sick
preterm infants who receive multiple
transfusions are at risk of iron over-
load. The use of recombinant human
erythropoietin to prevent transfusion
therapy in preterm infants will further
deplete iron stores if additional sup-
plemental iron is not provided. The
highly variable iron status of preterm
infants, along with their risks for ID as
well as toxicity, precludes determining
the exact requirement, but it can be
estimated to be between 2 and 4mg/kg
per day when given orally.9
Term Infants (Birth Through 12
Completed Months of Age)
The Institute of Medicine (IOM)10 used
the average iron content of human
milk to determine the adequate intake
of 0.27 mg/day for term infants from
birth through 6 months’ completed
age. The average iron content of hu-
man milk was determined to be 0.35
mg/L, and the averagemilk intake of an
exclusively breastfed infant was deter-
mined to be 0.78 L/day. Multiplying
these 2 numbers determined the ade-
quate intake of 0.27 mg/day for term
infants from birth through 6 months of
age in the IOM report. The IOM further
reasoned that there should be a direct
correlation between infant size and
human milk ingestion; therefore, no
correction need be made for infant
weight. It should be pointed out, how-
ever, that although bigger infants may
ingest more milk, there is a large vari-
ation in iron concentration of human
milk, and there is no guarantee that
the iron content of the maternal milk
matches the needs of the infant for
iron.
For infants from 7 to 12 months’ com-
pleted age, the recommended dietary
allowance for iron, according to the
IOM, is 11 mg/day, which was deter-
mined by using a factorial approach.
The amount of iron lost, primarily from
sloughed epithelial cells from skin and
the intestinal and urinary tracts, was
added to the amounts of iron required
for increased blood volume, increased
tissue mass, and storage iron during
this period of life. It was noted that the
iron needs of infants do not suddenly
jump from 0.27 to 11 mg/day at 6
months of age; this disjuncture is the
result of the use of very different meth-
ods of determining these values. How-
ever, it is clear that healthy, term new-
born infants require very little iron
early in life compared with the signiﬁ-
cant amounts of iron required after 6
months of age.
IRON REQUIREMENTS FOR
TODDLERS (1–3 YEARS OF AGE)
Using a similar factorial approach as
described for infants 7 to 12 months’
completed age, the IOM determined
that the recommended dietary allow-
ance for iron for children from 1
through 3 years of age is 7 mg/day.9
PREVALENCE OF ID AND IDA
There are currently no national statis-
tics for the prevalence of ID and IDA in
infants before 12 months’ completed
age. Hay et al11 reported on a cohort of
284 term Norwegian infants. Using the
deﬁnitions provided by Dallman12 in an
IOM report, the prevalence of ID at 6
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months of age was 4% and increased
to 12% at 12 months of age.
The prevalence of ID and IDA among
toddlers (1–3 years of age) in the
United States is listed in Table 1 and
was derived from National Health and
Nutrition Examination Survey data col-
lected between 1999 and 2002.7,8 The
overall prevalence of anemia and pos-
sibly ID and IDA in infants and toddlers
has declined since the 1970s.2 Al-
though there is no direct proof, this
decline has been attributed to use
of iron-fortiﬁed formulas and iron-
fortiﬁed infant foods provided by the
Special Supplemental Program for
Women, Infants, and Children (WIC) in
the early 1970s and the decrease in
use of whole cowmilk for infants.8 Still,
ID remains relatively common and oc-
curs in 6.6% to 15.2% of toddlers, de-
pending on ethnicity and socioeco-
nomic status. The prevalence of IDA is
0.9% to 4.4%, again depending on race/
ethnicity and socioeconomic status,7,8
but only accounts for approximately
40% of the anemia in toddlers (Table
1). These numbers are comparable to
data collected in other industrialized
countries.13,14
Related to the problem of ID/IDA is the
interaction of iron and lead. Results of
both animal and human studies have
conﬁrmed that IDA increases intestinal
lead absorption.15–17 A reasonably well-
established epidemiologic association
has been made between IDA and in-
creased lead concentrations.18 Thus,
primary prevention of IDA could also
serve as primary prevention of lead
poisoning. This possibility is all the
more attractive, because lead has
been reported to induce neurotoxicity
at even very low blood concentra-
tions.19,20 In addition, preexisting IDA
decreases the efﬁciency of lead chela-
tion therapy, and iron supplementa-
tion corrects this effect. In contrast,
iron supplementation in a child with
IDA who also has lead poisoning with-
out chelation therapy seems to in-
crease blood lead concentrations and
decrease basal lead excretion.21,22 The
effect of iron supplementation on
blood lead concentrations in iron-
replete children with or without lead
poisoning is not known. Thus, in the-
ory, selective rather than universal
iron supplementation would be more
likely to reduce lead poisoning and
its potential harmful effects on these
children.
ID AND NEURODEVELOPMENT
The possible relationship between ID/
IDA and later neurobehavioral develop-
ment in children is the subject of many
reports.3,23–31 Results of a preponder-
ance of studies have demonstrated an
association between IDA in infancy and
later cognitive deﬁcits. Lozoff et al3,25
have reported detecting cognitive def-
icits 1 to 2 decades after the iron-
deﬁcient insult during infancy. How-
ever, it has been difﬁcult to establish a
causal relationship because of the
many confounding variables and the
difﬁculty in designing and executing
the large, randomized controlled trials
necessary to distinguish small poten-
tial differences. The authors of a Co-
chrane Database systematic review, in
which the question of whether treat-
ment of IDA improved psychomotor de-
velopment was examined, stated that
there was inconclusive but plausible
evidence (only 2 randomized con-
trolled trials) demonstrating improve-
ment if the treatment extended for
more than 30 days.27 McCann and
Ames28 recently reviewed the evidence
of a causal relationship between ID/IDA
and deﬁcits in cognitive and behav-
ioral function. They concluded that for
IDA, there is at least some support
for causality, but because speciﬁcity
for both cause and effect have not
been established unequivocally, it is
premature to conclude the existence
of a causal relationship between IDA
and cognitive and behavioral perfor-
mance. For ID, some evidence of cau-
sality exists, but it is less than that for
IDA.28
It is known that iron is essential
for normal neurodevelopment in a
number of animal models. ID affects
neuronal energy metabolism, the me-
tabolism of neurotransmitters, myeli-
nation, and memory function. These
observations would explain the behav-
ioral ﬁndings in human infants that
have been associated with ID.29–31
Therefore, taking into account that
iron is the world’s most common
TABLE 1 ID, IDA, and Anemia in the 1999–2002 National Health and Nutrition Examination Survey,7
Children 12 to 35 Months of Age
Population Sampled (No.) Proportion of US Toddler
Population, % (SE)a
ID, % (SE) IDA, % (SE) All Anemia,
% (SE)
General US population (672) 9.2 (1.3) 2.1 (0.6) 5.1 (0.8)
Above poverty line (355)b 66.4 (2.9) 8.9 (1.7) 2.2 (0.8)c 4.6 (1.1)
Below poverty line (268)b 33.6 (2.9) 8.6 (1.6) 2.3 (1.2)c 6.2 (1.3)
Enrolled in WIC (360)d 44.4 (3.2) 10.7 (2.1) 3.1 (1.2)c 6.6 (1.4)
Non-Hispanic white (196) 58.0 (3.8) 7.3 (1.9) 2.0 (0.8)c 4.6 (1.2)
Non-Hispanic black (173) 14.1 (2.1) 6.6 (1.8) 1.6 (0.9)c 8.3 (1.9)
Mexican American (231) 15.0 (2.2) 13.9 (3.1) 0.9 (0.7)c 3.2 (1.2)c
Other ethnicity (72) 13.0 (2.7) 15.2 (4.7)c 4.4 (2.7)c 5.5 (2.7)c
Shown are the unweighted number and weighted percentage and SEs for all children with complete data for Hb, SF,
transferrin saturation, and zinc protoporphyrin. Anemia was deﬁned as a Hb concentration of11.0 g/dL; ID7 was deﬁned
as an abnormal value for at least 2 of 3 indicators: SF (abnormal cutoff:10g/dL), zinc protoporphyrin (1.42mol/L red
blood cells), and transferrin saturation (10%); and IDA was deﬁned as anemia plus ID.
a Proportion of row descriptor of all children in analytic sample (N 672).
b Children with income data (N 623).
c Estimate is statistically unreliable. Relative SE (SE of estimate/estimate 100) 30%.
d Anymember of householdwho received beneﬁts fromWIC in the previous 12months: childrenwith food-security data (N
668).
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single-nutrient deﬁciency, it is impor-
tant to minimize IDA and ID among in-
fants and toddlers, even if an unequiv-
ocal relationship between IDA and ID
and neurodevelopmental outcomes
has yet to be established.
DIAGNOSIS
Iron status is a continuum. At one
end of the spectrum is IDA, and at
the other end is iron overload. ID and
IDA are attributable to an imbalance
between iron needs and available iron
that results in a deﬁciency of mobiliz-
able iron stores and is accompanied
by changes in laboratory measure-
ments that include Hb concentration,
mean corpuscular Hb concentration,
mean corpuscular volume, reticulo-
cyte Hb concentration (abbreviated
in the literature as CHr) content, to-
tal iron-binding capacity, transferrin
saturation, zinc protoporphyrin, SF
concentration, and serum transferrin
receptor 1 (TfR1) concentration. Mea-
surements that are used to describe
iron status are listed in Table 2.
In a child with ID, as the Hb concentra-
tion falls 2 SDs below the mean for age
and gender, IDA is present, by deﬁni-
tion; for infants at 12 months of age,
this is 11.0 mg/dL.7,8 When IDA ac-
counted for most cases of anemia in
children, “anemia” and “IDA” were
roughly synonymous, and a simple
measurement of Hb concentrationwas
sufﬁcient to make a presumptive diag-
nosis of anemia attributable to ID. Par-
ticularly in industrialized nations, the
prevalence of ID and IDA has de-
creased, and other causes of anemia,
such as hemolytic anemias, anemia of
chronic disease, and anemia attribut-
able to other nutrient deﬁciencies,
have become proportionately more
common.32
No single measurement is currently
available that will characterize the
iron status of a child. The limitations of
using Hb concentration as a measure
of iron status are its lack of speciﬁcity
and sensitivity. Factors that limit eryth-
ropoiesis or result in chronic hemoly-
sis, such as genetic disorders and
chronic infections, may result in low
Hb concentrations. Vitamin B12 or fo-
late deﬁciency, although uncommon in
the pediatric population, also can re-
sult in a low Hb concentration. The lack
of sensitivity is largely attributable to
the marked overlap in Hb concentra-
tions between populations with iron
sufﬁciency and those with ID.33 Thus, to
identify ID or IDA, Hb concentration
must be combined with other mea-
surements of iron status. Once the di-
agnosis of IDA has been established,
however, following Hb concentration
is a good measure of response to
treatment.
In establishing the deﬁnitive iron sta-
tus of an individual, it is desirable to
use the fewest tests that will accu-
rately reﬂect iron status. Any battery of
tests must include Hb concentration,
because it determines the adequacy
of the circulating red cell mass and
whether anemia is present. One or
more tests must be added to the deter-
mination of Hb concentration if ID or
IDA is to be diagnosed. The 3 parame-
ters that provide discriminatory infor-
mation about iron status are SF, CHr,
and TfR1 concentrations.
SF is a sensitive parameter for the as-
sessment of iron stores in healthy sub-
jects34–36; 1g/L of SF corresponds to 8
to 10mg of available storage iron.34,37,38
Measurement of SF concentration is
widely used in clinical practice and
readily available. Cook et al36 selected
an SF concentration below 12 g/L as
diagnostic for ID after a comprehen-
sive population survey in the United
States. Thus, a cutoff value of 12 g/L
has been widely used for adults and
denotes depletion of iron stores. In
children, a cutoff value of 10 g/L has
been suggested.39 Because SF is an
acute-phase reactant, concentrations
of SF may be elevated in the presence
of chronic inﬂammation, infection, ma-
lignancy, or liver disease, and a simul-
taneous measurement of C-reactive
protein (CRP) is required to rule out
inﬂammation. Although Brugnara et
al40 found SF concentration to be less
accurate than either the CHr or TfR1
concentration in establishing iron sta-
tus of children, combining SF concen-
tration with a determination of CRP is
currently more readily available to as-
sess iron stores and is a reliable
screening test as long as the CRP level
is not elevated41 (Table 2).
CHr and TfR1 concentrations are not
affected by inﬂammation (infection),
malignancy, or anemia of chronic dis-
ease and, thus, would be preferable as
biomarkers for iron status. Only the
CHr assay is currently available for use
in children. The CHr content assay has
been validated in children, and stan-
dard values have been determined.40,42
The CHr assay provides a measure of
iron available to cells recently re-
leased from the bone marrow. CHr
content can be measured by ﬂow cy-
tometry, and 2 of the 4 automated he-
matology analyzers commonly used in
the United States have the capability to
measure CHr.43 A low CHr concentra-
TABLE 2 Spectrum of Iron Status
Parameter ID
Without
Anemia
IDA Iron
Overload
SFa 2 22 1
Transferrin
saturation
2 2 11
TfR1 11 111 2
CHr 2 2 Normal
Hb Normal 2 Normal
Mean corpuscular
volume
Normal 2 Normal
a Confounded by the presence of inﬂammation. If SF is
normal or increased and the CRP level is normal, then
there is no ID. If SF is decreased, then ID is present regard-
less of the measure of CRP. If SF is normal or increased
and the CRP level is increased, then the presence of ID
cannot be determined.
Modiﬁed from American Academy of Pediatrics, Commit-
tee on Nutrition. Iron deﬁciency. In: Kleinman RE, ed. Pedi-
atric Nutrition Handbook. 5th ed. Elk Grove Village, IL:
American Academy of Pediatrics; 2004:304.
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tion has been shown to be the stron-
gest predictor of ID in children40,42,43
and shows much promise for the diag-
nosis of ID when the assay becomes
more widely available.
TfR1 is a measure of iron status, de-
tecting ID at the cellular level. TfR1 is
found on cell membranes and facili-
tates transfer of iron into the cell.
When the iron supply is inadequate,
there is an upregulation of TfR1 to en-
able the cell to compete more effec-
tively for iron, and subsequently, more
circulating TfR1 is found in serum. An
increase in serum TfR1 concentrations
is seen in patients with ID or IDA, al-
though it does not increase in serum
until iron stores are completely ex-
hausted in adults.44–46 However, the
TfR1 assay is not widely available, and
standard values for infants and chil-
dren have yet to be established.
Thus, to establish a diagnosis of IDA,
the following sets of tests can be used
at the present time (when coupled
with determination of a Hb concentra-
tion of11 g/dL): (1) SF and CRP mea-
surements or (2) CHr measurement.
For diagnosing ID without anemia,
measure either (1) SF and CRP or (2)
CHr.
Another approach to making the diag-
nosis of IDA in a clinically stable child
with mild anemia (Hb concentration
between 10 and 11 g/dL) is to monitor
the response to iron supplementation,
especially if a dietary history indicates
that the diet is likely to be iron deﬁ-
cient. An increase in Hb concentration
of 1 g/dL after 1 month of therapeutic
supplementation has been used to sig-
nify the presence of IDA. This approach
requires that iron supplementation
be adequate, iron be adequately ab-
sorbed, and patient compliance with
adequate follow-up can be ensured.
However, because only 40% of the
cases of anemia identiﬁed at 12
months of age will be secondary to IDA
(Table 1), strong consideration should
be given to establishing a diagnosis of
IDA by using the screening tests de-
scribed previously.
PREVENTION OF ID AND IDA
Preterm Infants
The preterm infant (37 weeks’ gesta-
tion) who is fed human milk should re-
ceive a supplement of elemental iron
at 2 mg/kg per day starting by 1 month
of age and extending through 12
months of age.47 This can be provided
as medicinal iron or in iron-fortiﬁed
complementary foods. Preterm infants
fed a standard preterm infant formula
(14.6 mg of iron per L) or a standard
term infant formula (12.0 mg of iron
per L) will receive approximately 1.8 to
2.2 mg/kg per day of iron, assuming a
formula intake of 150 mL/kg per day.
Despite the use of iron-containing for-
mulas, 14% of preterm infants develop
ID between 4 and 8 months of age.48
Thus, some formula-fed preterm in-
fants may need an additional iron
supplement,47 although there is not
enough evidence to make this a general
recommendationat this time. Exceptions
to this iron-supplementation practice in
preterm infantswouldbe infantswhore-
ceivedmultiple transfusions during hos-
pitalization, whomight not need any iron
supplementation.
Term, Breastfed Infants
Infants who are born at term usually
have sufﬁcient iron stores until 4 to 6
months of age.49 Infants born at term
have high Hb concentration and high
blood volume in proportion to body
weight. They experience a physiologic
decline in both blood volume and Hb
concentration during the ﬁrst several
months of life. These facts have led to
the supposition that breastfed infants
need very little iron. It is assumed that
the small amount of iron in human
milk is sufﬁcient for the exclusively
breastfed infant. The World Health
Organization recommends exclusive
breastfeeding for 6 months, and the
American Academy of Pediatrics (AAP)
has recommended exclusive breast-
feeding for aminimum of 4months but
preferably for 6 months. Exclusive
breastfeeding for more than 6 months
has been associated with increased
risk of IDA at 9 months of age.49,50 Rec-
ommendations for exclusive breast-
feeding for 6 months do not take into
account infants who are born with
lower-than-usual iron stores (low
birth weight infants, infants of diabetic
mothers), a condition that also has
been linked to lower SF concentrations
at 9 months of age.51 In a double-blind
study, Friel et al52 demonstrated that
exclusively breastfed infants supple-
mented with iron between 1 and 6
months of age had higher Hb concen-
tration and higher mean corpuscular
volume at 6 months of age than did
their unsupplemented peers. Supple-
mentation also resulted in better vi-
sual acuity and higher Bayley Psy-
chomotor Developmental Indices at 13
months. Thus, it is recommended that
exclusively breastfed term infants
receive an iron supplementation of 1
mg/kg per day, starting at 4 months of
age and continued until appropriate
iron-containing complementary foods
have been introduced (Tables 3 and 4).
For partially breastfed infants, the pro-
portion of human milk versus formula
is uncertain; therefore, beginning at 4
months of age, infants who receive
more than one-half of their daily feed-
ings as human milk and who are not
receiving iron-containing complemen-
tary foods should also receive 1 mg/kg
per day of supplemental iron.
Term, Formula-Fed Infants
For the term, formula-fed infant, the
level of iron fortiﬁcation of formula to
prevent ID remains controversial.53,54
For more than 25 years, 12 mg of iron
per L has been the level of fortiﬁcation
in standard term infant formulas in
the United States, consistent with
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guidelines of WIC for iron-fortiﬁed for-
mula (at least 10 mg/L), thus creating
a natural experiment. The level of 12
mg/L was determined by calculating
the total iron needs of the child from 0
to 12months of age, assuming average
birth weight and average weight gain
during the ﬁrst year. The calculation
also assumed that formula was the
only source of iron during this period.
Others have recommended lower
amounts of iron in infant formula,55
and there have been studies to exam-
ine iron-fortiﬁcation levels of less than
12 mg/L.56–61 However, it is the conclu-
sion of the AAP that infant formula that
contains 12 mg of elemental iron per L
is safe for its intended use. Although
there has been some concern about
linear growth in iron-replete infants
given medicinal iron,62 no published
studies have convincingly documented
decreased linear growth in iron-replete
infants receiving formulas containing
high amounts of iron. Evidence is also
insufﬁcient to associate formulas that
contain 12 mg of iron per L with gas-
trointestinal symptoms. At least 4
studies have shown no adverse ef-
fects.63–66 Reports have conﬂicted on
whether iron fortiﬁcation is associ-
ated with increased risk of infection.
Decreased incidence, increased inci-
dence, and no change in number of in-
fections have all been reported.67,68 The
authors of a recent systematic review
concluded that “iron supplementation
has no apparent harmful effect on
the overall incidence of infectious ill-
nesses in children, though it slightly
increases the risk of developing diar-
rhoea.”69 Finally, when examining spe-
ciﬁcally infants given formula with 12
mg of iron per L, Singhal et al70 were
“unable to identify adversehealth effects
in older infants and toddlers consuming
a high iron-containing formula.” They
found no difference between controls
and the treatment group in incidence of
infection, gastrointestinal problems, or
general morbidity.
TABLE 3 Foods to Increase Iron Intake and Iron Absorption
Elemental Iron, mg
Commercial baby food,a heme iron
Meat
Baby food, lamb, junior, 1 jar (2.5 oz) 1.2
Baby food, chicken, strained, 1 jar (2.5 oz) 1.0
Baby food, lamb, strained, 1 jar (2.5 oz) 0.8
Baby food, beef, junior, 1 jar (2.5 oz) 0.7
Baby food, beef, strained, 1 jar (2.5 oz) 0.7
Baby food, chicken, junior, 1 jar (2.5 oz) 0.7
Baby food, pork, strained, 1 jar (2.5 oz) 0.7
Baby food, ham, strained, 1 jar (2.5 oz) 0.7
Baby food, ham, junior, 1 jar (2.5 oz) 0.7
Baby food, turkey, strained, 1 jar (2.5 oz) 0.5
Baby food, veal, strained, 1 jar (2.5 oz) 0.5
Commercial baby food,a nonheme iron
Vegetables
Baby food, green beans, junior, 1 jar (6 oz) 1.8
Baby food, peas, strained, 1 jar (3.4 oz) 0.9
Baby food, green beans, strained, 1 jar (4 oz) 0.8
Baby food, spinach, creamed, strained, 1 jar (4 oz) 0.7
Baby food, sweet potatoes, junior (6 oz) 0.7
Cereals
Baby food, brown rice cereal, dry, instant, 1 tbsp 1.8
Baby food, oatmeal cereal, dry, 1 tbsp 1.6
Baby food, rice cereal, dry, 1 tbsp 1.2
Baby food, barley cereal, dry, 1 tbsp 1.1
Table food, heme iron
Clams, canned, drained solids, 3 oz 23.8
Chicken liver, cooked, simmered, 3 oz 9.9
Oysters, Eastern canned, 3 oz 5.7
Beef liver, cooked, braised, 3 oz 5.6
Shrimp, cooked moist heat, 3 oz 2.6
Beef, composite of trimmed cuts, lean only, all grades, cooked, 3 oz 2.5
Sardines, Atlantic, canned in oil, drained solids with bone, 3 oz 2.5
Turkey, all classes, dark meat, roasted, 3 oz 2.0
Lamb, domestic, composite of trimmed retail cuts, separable lean only,
choice, cooked, 3 oz
1.7
Fish, tuna, light, canned in water, drained solids, 3 oz 1.3
Chicken, broiler or fryer, dark meat, roasted, 3 oz 1.1
Turkey, all classes, light meat, roasted, 3 oz 1.1
Veal, composite of trimmed cuts, lean only, cooked, 3 oz 1.0
Chicken, broiler or fryer, breast, roasted, 3 oz 0.9
Pork, composite of trimmed cuts (leg, loin, shoulder), lean only, cooked, 3 oz 0.9
Fish, salmon, pink, cooked, 3 oz 0.8
Table food, nonheme iron
Oatmeal, instant, fortiﬁed, cooked, 1 cup 14.0
Blackstrap molasses,b 2 tbsp 7.4
Tofu, raw, regular, 1⁄2 cup 6.7
Wheat germ, toasted, 1⁄2 cup 5.1
Ready-to-eat cereal, fortiﬁed at different levels, 1 cup 4.5 to 18
Soybeans, mature seeds, cooked, boiled, 1⁄2 cup 4.4
Apricots, dehydrated (low-moisture), uncooked, 1⁄2 cup 3.8
Sunﬂower seeds, dried, 1⁄2 cup 3.7
Lentils, mature seeds, cooked, 1⁄2 cup 3.3
Spinach, cooked, boiled, drained, 1⁄2 cup 3.2
Chickpeas, mature seeds, cooked, 1⁄2 cup 2.4
Prunes, dehydrated (low-moisture), uncooked, 1⁄2 cup 2.3
Lima beans, large, mature seeds, cooked, 1⁄2 cup 2.2
Navy beans, mature seeds, cooked, 1⁄2 cup 2.2
Kidney beans, all types, mature seeds, cooked, 1⁄2 cup 2.0
Molasses, 2 tbsp 1.9
Pinto beans, mature seeds, cooked, 1⁄2 cup 1.8
Raisins, seedless, packed, 1⁄2 cup 1.6
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Toddlers (1–3 Years of Age)
The iron requirement for toddlers is 7
mg/day. Ideally, the iron requirements
of toddlers would be met and ID/IDA
would be prevented with naturally
iron-rich foods rather than iron sup-
plementation. These foods include
those with heme sources of iron (ie,
red meat) and nonheme sources of
iron (ie, legumes, iron-fortiﬁed cere-
als) (Table 3). Foods that contain vita-
min C (ascorbic acid), such as orange
juice, aid in iron absorption and are
listed in Table 4. Foods that contain
phytates (found in soy) reduce iron ab-
sorption. Through public education
and altering feeding practices, the
amount of iron available to older in-
fants and toddlers via a normal diet
could be maximized (Table 3).
In developing countries, iron require-
ments of older infants and toddlers
have been met by iron fortiﬁcation of
various foods, including corn ﬂour,71
soy sauce,72 ﬁsh sauce,73 and rice.74
However, there aremany technical and
practical barriers to a successful for-
tiﬁcation program for toddlers. Not the
least of these barriers is the determi-
nation of which foods to fortify with
iron. In the United States, fortiﬁcation
of infant formula and infant cereal has
been credited with the decline in IDA.
However, toddlers in the United States
typically do not eat enough of any other
food to serve as a vehicle for iron for-
tiﬁcation. Universal food fortiﬁcation
for all ages is problematic, given the
possible adverse effects of iron in cer-
tain subsets of older children and
adults.
As an alternative for toddlers who do
not eat adequate amounts of iron-
containing food (Table 3), iron supple-
ments are available in the form of iron
sulfate drops and chewable iron tab-
lets or as a component of either liquid
or chewable multivitamins. Iron sprin-
kles with or without additional zinc are
available in Canada. Barriers to ade-
quate iron supplementation are (1)
lack of education for care providers
and patients, (2) poor compliance
made worse by the perception of ad-
verse effects, including nausea, vomit-
ing, constipation, stomach upset, and
teeth staining, (3) cost, (4) current fed-
eral supplemental nutrition programs
not providing iron supplements, and
(5) risk of iron overload.
Screening for ID and IDA
The AAP has concluded that universal
screening for anemia should be per-
formed with determination of Hb con-
centration at approximately 1 year of
age. Universal screening would also in-
clude an assessment of risk factors as-
sociated with ID/IDA: history of prema-
turity or low birth weight; exposure to
lead; exclusive breastfeeding beyond 4
months of age without supplemental
iron; and weaning to whole milk or
complementary foods that do not in-
clude iron-fortiﬁed cereals or foods
naturally rich in iron (Table 3). Addi-
tional risk factors include the feeding
problems, poor growth, and inade-
quate nutrition typically seen in infants
with special health care needs as well
as low socioeconomic status, espe-
cially children of Mexican American
descent, as identiﬁed in the recent
National Health and Nutrition Examina-
tion Survey8,75 (Table 1). Selective
screening can be performed at any age
when these risk factors for ID and IDA
have been identiﬁed, including risk of
inadequate iron intake according to di-
etary history.
It has been acknowledged that screen-
ing for anemiawith a Hb determination
neither identiﬁes children with ID nor
speciﬁcally identiﬁes those with IDA.76
In the United States, 60% of anemia is
not attributable to ID, and most tod-
TABLE 3 Continued
Elemental Iron, mg
Prunes, dehydrated (low moisture), stewed, 1⁄2 cup 1.6
Prune juice, canned, 4 ﬂ oz 1.5
Green peas, cooked, boiled, drain, 1⁄2 cup 1.2
Enriched white rice, long-grain, regular, cooked, 1⁄2 cup 1.0
Whole egg, cooked (fried or poached), 1 large egg 0.9
Enriched spaghetti, cooked, 1⁄2 cup 0.9
White bread, commercially prepared, 1 slice 0.9
Whole-wheat bread, commercially prepared, 1 slice 0.7
Spaghetti or macaroni, whole wheat, cooked, 1⁄2 cup 0.7
Peanut butter, smooth style, 2 tbsp 0.6
Brown rice, medium-grain, cooked, 1⁄2 cup 0.5
Note that all ﬁgures are rounded.
a Baby food values are generally based on generic jar, not branded jar; 3 oz of table-food meat 85 g; a 2.5-oz jar of baby
food 71 g (an infant would not be expected to eat 3 oz [approximately the size of a deck of cards] of pureed table meat at
a meal).
b Source of iron value was obtained from a manufacturer of this type of molasses.
Source of iron values in foods: US Department of Agriculture, Agricultural Research Service. USDA National Nutrient
Database for Standard Reference, Release 20: Nutrient Data Laboratory home page. Available at: www.ars.usda.gov/ba/
bhnrc/ndl.
TABLE 4 Selected Good Vitamin C Sources to Increase Iron Absorption
Fruits Vegetables
Citrus fruits (eg, orange, tangerine, grapefruit) Green, red, and yellow peppers
Pineapples Broccoli
Fruit juices enriched with vitamin C Tomatoes
Strawberries Cabbages
Cantaloupe Potatoes
Kiwifruit Leafy green vegetables
Raspberries Cauliﬂower
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dlerswith ID do not have anemia (Table
2). It is also known that there is poor
follow-up testing and poor documenta-
tion of improved Hb concentrations. In
1 study, 14% of the children had a pos-
itive screening result for anemia. How-
ever, only 18.3% of these children
with a positive screening result had
follow-up testing performed, and of
that group, only 11.6% had docu-
mented correction of low Hb levels.77
Therefore, for infants identiﬁed with a
Hb concentration of less than 11.0
mg/dL or identiﬁed with signiﬁcant
risk of ID or IDA as described previ-
ously, SF and CRP or CHr levels in addi-
tion to Hb concentration should be
measured to increase the sensitivity
and speciﬁcity of the diagnosis. In addi-
tion, the AAP, the World Health Organiza-
tion, and the European Society for Pedi-
atric Gastroenterology, Hepatology and
Nutrition also support the use of the
measurement of TfR1asa screening test
once themethod has been validated and
normal values for infants and toddlers
have been established.
Another step to improve the current
screening system is to use technology-
based reminders for screening and
follow-up of infants and toddlers with a
diagnosis of ID/IDA. Reminders could
be incorporated into electronic health
records, and there should be docu-
mentation that Hb concentrations have
returned to the normal range. The efﬁ-
cacy of any program for minimizing ID
and IDA should be tracked scientiﬁ-
cally and evaluated through well-
planned surveillance programs.
SUMMARY
Given that iron is the world’s most
common single-nutrient deﬁciency
and there is some evidence of adverse
effects of both ID and IDA on cognitive
and behavioral development, it is im-
portant to minimize ID and IDA in in-
fants and toddlers without waiting for
unequivocal evidence. Controversies
remain regarding the timing and
methods used for screening for ID/IDA
as well as regarding the use of iron
supplements to prevent ID/IDA. Al-
though further study is required to
generate higher levels of evidence to
settle these controversies, the cur-
rently available evidence supports the
following recommendations.
1. Term, healthy infants have sufﬁ-
cient iron for at least the ﬁrst 4
months of life. Humanmilk contains
very little iron. Exclusively breast-
fed infants are at increasing risk of
ID after 4 completed months of age.
Therefore, at 4 months of age,
breastfed infants should be supple-
mentedwith 1mg/kg per day of oral
iron beginning at 4 months of age
until appropriate iron-containing
complementary foods (including
iron-fortiﬁed cereals) are intro-
duced in the diet (see Table 3). For
partially breastfed infants, the pro-
portion of human milk versus for-
mula is uncertain; therefore, begin-
ning at 4 months of age, partially
breastfed infants (more than half
of their daily feedings as human
milk) who are not receiving iron-
containing complementary foods
should also receive 1mg/kg per day
of supplemental iron.
2. For formula-fed infants, the iron
needs for the ﬁrst 12 months of life
can be met by a standard infant for-
mula (ironcontent: 12mg/dL) and the
introduction of iron-containing com-
plementary foods after 4 to 6 months
of age, including iron-fortiﬁed cereals
(Table 3). Whole milk should not be
used before 12 completed months
of age.
3. The iron intake between 6 and 12
months of age should be 11mg/day.
When infants are given complemen-
tary foods, redmeat and vegetables
with higher iron content should be
introduced early (Table 3). To aug-
ment the iron supply, liquid iron
supplements are appropriate if
iron needs are not being met by the
intake of formula and complemen-
tary foods.
4. Toddlers 1 through 3 years of age
should have an iron intake of 7 mg/
day. This would be best delivered by
eating red meats, cereals fortiﬁed
with iron, vegetables that contain
iron, and fruits with vitamin C,
which augments the absorption of
iron (Tables 3 and 4). For toddlers
not receiving this iron intake, liquid
supplements are suitable for chil-
dren 12 through 36 months of age,
and chewable multivitamins can be
used for children 3 years and older.
5. All preterm infants should have an
iron intake of at least 2 mg/kg per
day through 12 months of age,
which is the amount of iron sup-
plied by iron-fortiﬁed formulas. Pre-
term infants fed humanmilk should
receive an iron supplement of 2
mg/kg per day by 1 month of age,
and this should be continued until
the infant is weaned to iron-fortiﬁed
formulaorbeginseatingcomplemen-
tary foods that supply the 2 mg/kg of
iron. An exception to this practice
would include infants who have re-
ceived an iron load from multiple
transfusions of packed red blood
cells.
6. Universal screening for anemia
should be performed at approxi-
mately 12 months of age with deter-
mination of Hb concentration and
an assessment of risk factors asso-
ciated with ID/IDA. These risk fac-
tors would include low socioeco-
nomic status (especially children of
Mexican American descent [Table
1]), a history of prematurity or low
birth weight, exposure to lead, ex-
clusive breastfeeding beyond 4
months of age without supplemen-
tal iron, and weaning to whole milk
or complementary foods that do not
include iron-fortiﬁed cereals or
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foods naturally rich in iron (Table
3). Additional risk factors are the
feeding problems, poor growth, and
inadequate nutrition typically seen
in infants with special health
care needs. For infants and tod-
dlers (1–3 years of age), additional
screening can be performed at any
time if there is a risk of ID/IDA, in-
cluding inadequate dietary iron
intake.
7. If the Hb level is less than 11.0
mg/dL at 12months of age, then fur-
ther evaluation for IDA is required
to establish it as a cause of anemia.
If there is a high risk of dietary ID as
described in point 6 above, then fur-
ther testing for ID should be per-
formed, given the potential adverse
effects on neurodevelopmental out-
comes. Additional screening tests
for ID or IDA should include mea-
surement of:
● SF and CRP levels; or
● CHr concentration.
8. If a child has mild anemia (Hb level
of 10–11 mg/dL) and can be closely
monitored, an alternative method
of diagnosis would be to document
a 1 g/dL increase in plasma Hb con-
centration after 1 month of appro-
priate iron-replacement therapy,
especially if the history indicates
that the diet is likely to be iron
deﬁcient.
9. Use of the TfR1 assay as screening
for ID is promising, and the AAP sup-
ports the development of TfR1 stan-
dards for use of this assay in in-
fants and children.
10. If IDA (or any anemia) or ID has
been conﬁrmed by history and lab-
oratory evidence, a means of care-
fully tracking and following infants
and toddlers with a diagnosis of
ID/IDA should be implemented.
Electronic health records could be
used not only to generate re-
minder messages to screen for
IDA and ID at 12 months of age but
also to document that IDA and ID
have been adequately treated
once diagnosed.
ADDENDUM
Development of This Report
This report was written by the primary
authors after extensive review of the
literature using PubMed, previous AAP
reports, Cochrane reviews, and re-
ports from other groups.1,6,7,48,77
The report was also submitted to the
following sections and committees of
the AAP that were asked to comment
on the manuscript: Committee on Fe-
tus and Newborn (COFN); Committee
on Practice and Ambulatory Medicine
(COPAM); Committee on Psychosocial
Aspects of Child and Family Health
(COPACFH); Section on Administration
and Practice Management (SOAPM);
Section on Developmental and Behav-
ioral Pediatrics (SODBP); Section on
Gastroenterology, Hepatology, and Nu-
trition (SOGHN); Section on Hematol-
ogy and Oncology (SOHO); and Section
on Breast Feeding (SOBr).
Additional comments were sought
from the Centers for Disease Control
and Prevention (CDC), the Department
of Agriculture (WIC), the National Insti-
tutes of Health (NIH), and the Food and
Drug Administration (FDA), because
these governmental agencies were in-
volved in the development of the state-
ment and will necessarily deal with its
impact. As it was developed it was ex-
tensively reviewed and revised by
members of the AAP Committee on Nu-
trition, who unanimously approved
this clinical report. It is openly ac-
knowledged that where the highest
levels of evidence are absent, the opin-
ions and suggestions of members of
the Committee on Nutrition as well as
other groups consulted for this state-
ment were taken into consideration in
developing this clinical report.
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